Cosmax BTI (044820) Fundamentals 2026 — P/E 5.3x, Revenue Analysis | SniperIQ
Cosmax BTI (044820) is a KR-listed Consumer Defensive company in Household & Personal Products with a market capitalization of ₩181.4B, trading at ₩18980.00 on the KSC. This SniperIQ fundamentals page covers Cosmax BTI's valuation (P/E 5.3x, P/B 0.6x), profitability (net margin 6.1%), revenue (₩645.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Cosmax BTI's market cap?
Cosmax BTI (044820) has a market capitalization of approximately ₩181.4B, trading at ₩18980.00 on the KSC. Market cap moves with the live share price.
What is Cosmax BTI's P/E ratio?
Cosmax BTI's trailing twelve-month P/E ratio is 5.3x, with a price-to-book (P/B) of 0.6x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is Cosmax BTI?
Cosmax BTI runs a net profit margin of 6.1%, a gross margin of 21.1%, and an operating margin of 5.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Cosmax BTI generate?
Cosmax BTI reported revenue of ₩645.2B for fiscal year 2025, with net income of ₩29.2B and earnings per share (EPS) of 3056.92. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Cosmax BTI pay a dividend?
Cosmax BTI offers a trailing dividend yield of about 4.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Cosmax BTI financially healthy?
Cosmax BTI carries a debt-to-equity ratio of 1.75x and a current ratio of 0.60x, with a market beta of 0.65. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Cosmax BTI a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Cosmax BTI (044820) the key facts are: market cap ₩181.4B, P/E 5.3x, revenue ₩645.2B, 52-week range 11810-23900. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track Cosmax BTI's full fundamentals live
Get Cosmax BTI's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.